The Endocrine Society is set to debut its new Center on Obesity and a Scientific Statement on obesity science and research gaps. The virtual event on September 9 will feature expert presentations and discussions on the latest developments in obesity treatments and research.
South Carolina and 13 other states are covering GLP-1s, a class of weight loss drugs, for Medicaid beneficiaries, despite the federal government's decision not to finalize a rule that would have allowed millions to access the treatment.
Medicare to cover weight loss drugs like Wegovy and Zepbound for $50 a month under a new pilot program, a significant shift for the healthcare system. The program aims to increase accessibility for older Americans struggling with obesity.
A new pilot program will allow some Medicare recipients to access GLP-1 weight loss medications for $50 a month, potentially helping millions of older adults who struggle with obesity. The program, set to launch on July 1, will cover three drugs and be available to those with Medicare Part D who meet certain conditions.